The commencement of antibiotic compounding at Slade Health New Zealand follows closely on the heels of the facility’s first-ever chemotherapy dose compounding, which took place just over six months ago.
Located in the heart of Auckland, the facility is a testament to Slade Health’s commitment to world-class sterile manufacturing, catering to New Zealand’s healthcare needs. The team of 35, which includes pharmacists, technicians, logistics and administration, produce and dispatch approximately 300 essential infusions to New Zealanders every day.